Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide

Ashley M. Hopkins, Agnes I. Vitry, Catherine E. O'Doherty, Susanna M. Proudman, Michael D. Wiese

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1795-1797
Number of pages3
JournalInternational Journal of Rheumatic Diseases
Issue number11
Publication statusPublished or Issued - Nov 2017
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology

Cite this